Federal Funding Opportunities
Browse federal grant and contract opportunities from Grants.gov and SAM.gov
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
National Institutes of Health
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDA R25 program is to support educational activities th…
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through t…
U.S. Embassy The Hague PD Annual Program Statement
U.S. Mission to the Netherlands
ANNUAL PROGRAM STATEMENT Funding Opportunity Title: U.S. Embassy The Hague PD Annual Program Statement Funding Opportunity Number: PD-THEHAGUE-FY25-01 Deadline for Applications: November 15, 2024 (Ad…
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
National Institutes of Health
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics rele…
Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language devel…
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
National Institutes of Health
This Notice of Funding Opportunity (NOFO) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular …
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
National Institutes of Health
Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation…
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
National Institutes of Health
The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons w…
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through t…
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
National Institutes of Health
The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonist…
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients …
National Institutes of Health
The Office of Research Infrastructure Programs (ORIP) within the Division of Program Coordination, Planning, and Strategic Initiatives announces an opportunity to apply for small grant support for OR…
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 …
National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary d…